Post-COVID-19 complications involve a variety of long-lasting health complications emerging in various body systems. Since the prevalence of post-COVID-19 complications ranges from 8-47% in COVID-19 survivors, it represents a formidable challenge to COVID-19 survivors and the health care system. Post-COVID-19 complications have already been studied in the connection to risk factors linked to their higher probability of occurrence and higher severity, potential mechanisms underlying the pathogenesis of post-COVID-19 complications, and their functional and structural correlates. Vaccination status has been recently revealed to represent efficient prevention from long-term and severe post-COVID-19 complications. However, the exact mechanisms responsible for vaccine-induced protection against severe and long-lasting post-COVID-19 complications remain elusive. Also, to the best of our knowledge, the effects of new SARS-CoV-2 variants and SARS-CoV-2 reinfections on post-COVID-19 complications and their underlying pathogenesis remain to be investigated. This hypothesis article will be dedicated to the potential effects of vaccination status, SARS-CoV-2 reinfections, and new SARS-CoV-2 variants on post-COVID-19 complications and their underlying mechanisms Also, potential prevention strategies against post-COVID complications will be discussed.

Department of Medical Biophysics and Medical Informatics 3rd Faculty of Medicine Charles University Prague Prague Czechia

See more in PubMed

Hepsomali P, Groeger JA, Nishihira J, Scholey A. Effects of oral gamma-aminobutyric acid (GABA) administration on stress and sleep in humans: a systematic review. Front Neurosci. (2020) 14:923. 10.3389/fnins.2020.00923 PubMed DOI PMC

Fernández-De-las-peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Cuadrado ML, Florencio LL. Defining post-covid symptoms (Post-acute covid, long covid, persistent post-covid): An integrative classification. Int J Environ Res Public Health. (2021) 18:1–9. 10.3390/ijerph18052621 PubMed DOI PMC

Kayaaslan B, Eser F, Kalem AK, Kaya G, Kaplan B, Kacar D, et al. . Post-COVID syndrome: a single-center questionnaire study on 1007 participants recovered from COVID-19. J Med Virol. (2021) 93:6566–74. 10.1002/jmv.27198 PubMed DOI PMC

Pilotto A, Cristillo V, Cotti Piccinelli S, Zoppi N, Bonzi G, Sattin D, et al. . Long-term neurological manifestations of COVID-19: prevalence and predictive factors. Neurol Sci. (2021) 1–16. 10.1101/2020.12.27.20248903 PubMed DOI PMC

Fernández-de-las-Peñas C, Florencio LL, Gómez-Mayordomo V, Cuadrado ML, Palacios-Ceña D, Raveendran AV. Proposed integrative model for post-COVID symptoms. Diabetes Metab Syndr Clin Res Rev. (2021) 15:15–7. 10.1016/j.dsx.2021.05.032 PubMed DOI PMC

Parums DV. Editorial : the 2022 world health organization (WHO) priority recommendations and response to the omicron variant (B. 1 1 529) of SARS–CoV−2. Med Sci Monit. (2022) 28:e936199. 10.12659/MSM.936199 PubMed DOI PMC

Cheon IS, Li C, Son YM, Goplen NP, Wu Y, Cassmann T, et al. . Immune signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol. (2021) 6:eabk1741. 10.1126/sciimmunol.abk1741 PubMed DOI PMC

Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, et al. . 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. (2021) 48:2823–33. 10.1007/s00259-021-05215-4 PubMed DOI PMC

Yong SJ. Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. (2021) 12:573–80. 10.1021/acschemneuro.0c00793 PubMed DOI

Barizien N, Le Guen M, Russel S, Touche P, Huang F, Vallée A. Clinical characterization of dysautonomia in long COVID-19 patients. Sci Rep. (2021) 11:1–7. 10.1038/s41598-021-93546-5 PubMed DOI PMC

Mahmud R, Rahman MM, Rassel MA, Monayem FB, Sayeed SKJB, Islam MS, et al. . Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh. PLoS ONE. (2021) 16:1–13. 10.1371/journal.pone.0249644 PubMed DOI PMC

Walsh-Messinger J, Manis H, Vrabec A., Sizemore BS J, Bishof K, et al. . The kids are not alright: a preliminary report of Post-COVID syndrome in university students. J Am Coll Heal. (2021) 0:1–7. 10.1080/07448481.2021.1927053 PubMed DOI PMC

Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, et al. . Acute COVID-19 Syndrome. San Francisco, CA: (2019) PubMed PMC

Beghi E, Giussani G, Westenberg E, Allegri R, Garcia-Azorin D, Guekht A, et al. . Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions. J Neurol. (2021) 10.1007/s00415-021-10848-4 PubMed DOI PMC

Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Pang P, et al. . Long COVID in patients with mild to moderate disease: do thyroid function and autoimmunity play a role? Endocr Pract. (2021) 27:894–902. 10.1016/j.eprac.2021.06.016 PubMed DOI PMC

Vol ER, Zambrano LD, Newhams MM, Olson SM, Halasa NB, Price AM. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12 – 18 Years — United States, July – December 2021. (2021) 71:52–4. PubMed PMC

Kuodi P, Gorelik Y, Zayyad H, Jabal A, Wertheim O, Wiegler KB, et al. . Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021. (2022) 70:1081–3. 10.1101/2022.01.05.22268800 DOI

Barda N, Dagan N, Cohen C, Hernán MA, Lipsitch M, Kohane IS, et al. . Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet. (2021) 398:2093–100. 10.1016/S0140-6736(21)02249-2 PubMed DOI PMC

Fakhroo A, Alkhatib HA, Al Thani AA, Yassine HM. Reinfections in COVID-19 patients: impact of virus genetic variability and host immunity. Vaccines. (2021) 9:1–9. 10.3390/vaccines9101168 PubMed DOI PMC

Levine-Tiefenbrun M, Yelin I, Katz R, Herzel E, Golan Z, Schreiber L, et al. . Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine. Nat Med. (2021) 27:790–2. 10.1038/s41591-021-01316-7 PubMed DOI

Cavanaugh AM, Spicer KB, Thoroughman D. Glick. Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination Science (80-). (2021) 372:1413–8. 10.15585/mmwr.mm7032e1 PubMed DOI PMC

Arnold DT, Milne A, Samms E, Stadon L, Maskell NA, Hamilton FW. Are vaccines safe in patients with Long COVID? A prospective observational study. medRxiv [Preprint]. (2021) 10.1101/2021.03.11.21253225 DOI

Kabeerdoss J, Pilania RK, Karkhele R, Kumar TS, Danda D, Singh S. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int. (2021) 41:19–32. 10.1007/s00296-020-04749-4 PubMed DOI PMC

Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, et al. . Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. (2020) 369:m2094. 10.1136/bmj.m2094 PubMed DOI PMC

Boudhabhay I, Rabant M, Roumenina LT, Coupry LM, Poillerat V, Marchal A, et al. . Case report: adult post-COVID-19 multisystem inflammatory syndrome and thrombotic microangiopathy. Front Immunol. (2021) 12:680567. 10.3389/fimmu.2021.680567 PubMed DOI PMC

Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. medRxiv [Preprint]. (2021) 1–27. 10.1101/2021.10.26.21265508 PubMed DOI PMC

Penetra SLS, da Silva MFB, Resende P, Pina-Costa A, Santos HFP, Guaraldo L, et al. . Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 gamma variant in Brazil. Int J Infect Dis. (2022) 114:58–61. 10.1016/j.ijid.2021.10.048 PubMed DOI PMC

Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. . Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. (2022) 22:43–55. 10.1016/S1473-3099(21)00460-6 PubMed DOI PMC

McQuaid C, Brady M, Deane R. SARS-CoV-2: is there neuroinvasion? Fluids Barriers CNS. (2021) 18:1–21. 10.1186/s12987-021-00267-y PubMed DOI PMC

Ayat P, Burza A, Habeeb C. Hypocortisolism in a patient with Covid-19: a case report and discussion on management. Chest. (2021) 160:A715. 10.1016/j.chest.2021.07.678 DOI

Novick TK, Rizzolo K, Cervantes L. COVID-19 and kidney disease disparities in the United States. Adv Chronic Kidney Dis. (2020) 27:427–33. 10.1053/j.ackd.2020.06.005 PubMed DOI PMC

Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. (2021) 93:250–6. 10.1002/jmv.26232 PubMed DOI PMC

Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL, et al. . Characterization and biomarker analyses of post-covid-19 complications and neurological manifestations. Cells. (2021) 10:1–18. 10.3390/cells10020386 PubMed DOI PMC

Wagner-Skacel J, Dalkner N, Moerkl S, Kreuzer K, Farzi A, Lackner S, et al. . Sleep and microbiome in psychiatric diseases. Nutrients. (2020) 12:1–18. 10.3390/nu12082198 PubMed DOI PMC

Zhou Y, Zhang J, Zhang D, Ma W, Wang X. Linking the gut microbiota to persistent symptoms in survivors of COVID−19 after discharge. J Microbiol. (2021) 59:941–8. 10.1007/s12275-021-1206-5 PubMed DOI PMC

Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GCY, Ng SSS, et al. . Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. (2022) 71:544–52. 10.1136/gutjnl-2021-325989 PubMed DOI

Roberts JA. Pathogenesis of pyelonephritis. J Urol. (1983) 129:1102–6. 10.1016/S0022-5347(17)52592-6 PubMed DOI

Roberts JA. Etiology and pathophysiology of pyelonephritis. Am J Kidney Dis. (1991) 17:1–9. 10.1016/S0272-6386(12)80242-3 PubMed DOI

Jiang S, Xie S, Lv D, Wang P, He H, Zhang T, et al. . Alteration of the gut microbiota in Chinese population with chronic kidney disease. Sci Rep. (2017) 7:1–10. 10.1038/s41598-017-02989-2 PubMed DOI PMC

Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. (2021) 8:416–27. 10.1016/S2215-0366(21)00084-5 PubMed DOI PMC

Szeto CC, Chow KM, Kwan BCH, Law MC, Chung KY Yu S, et al. . Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases. Clin J Am Soc Nephrol. (2007) 2:245–51. 10.2215/CJN.03180906 PubMed DOI

Grothe C, Taminato M, Belasco A, Sesso R, Barbosa D. Prophylactic treatment of chronic renal disease in patients undergoing peritoneal dialysis and colonized by Staphylococcus aureus: a systematic review and meta-analysis. BMC Nephrol. (2016) 17:115. 10.1186/s12882-016-0329-0 PubMed DOI PMC

Vezzani A. Epilepsy and inflammation in the brain: overview and pathophysiology. Epilepsy Curr. (2014) 14:3–7. 10.5698/1535-7511-14.s2.3 PubMed DOI PMC

Libby P, Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. (2020) 41:3038–44. 10.1093/eurheartj/ehaa623 PubMed DOI PMC

Rad F, Dabbagh A, Dorgalaleh A, Biswas A. The relationship between inflammatory cytokines and coagulopathy in patients with COVID-19. J Clin Med. (2021) 10:2020. 10.3390/jcm10092020 PubMed DOI PMC

Vasquez-Bonilla WO, Orozco R, Argueta V, Sierra M, Zambrano LI, Muñoz-Lara F, et al. . A review of the main histopathological findings in coronavirus disease 2019. Hum Pathol. (2020) 105:74–83. 10.1016/j.humpath.2020.07.023 PubMed DOI PMC

Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, et al. . Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. (2021) 24:168–75. 10.1101/2020.06.04.135012 PubMed DOI

Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. . Neurological associations of COVID-19. Lancet Neurol. (2020) 19:767–83. 10.1016/S1474-4422(20)30221-0 PubMed DOI PMC

Zhao H, Lu L, Peng Z, Chen LL, Meng X, Zhang C, et al. . SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerg Microbes Infect. (2022) 11:277–83. 10.1080/22221751.2021.2023329 PubMed DOI PMC

Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med. (2021) 27:601–15. 10.1038/s41591-021-01283-z PubMed DOI PMC

Puhach O, Adea K, Hulo N, Sattonnet P, Genecand C, Iten A. Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron SARS–CoV−2. Nat Med. (2022) 10.1101/2022.01.10.22269010 PubMed DOI

Samkaria A, Punjabi K, Sharma S, Joon S, Sandal K, Dasgupta T, et al. . Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: new avenue of mental health status monitoring. J Alzheimer's Dis. (2021) 83:523–30. 10.3233/JAD-210287 PubMed DOI

Sudre CH, Lee KA, Lochlainn MN, Varsavsky T, Murray B, Graham MS, et al. . Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID symptom study app. Sci Adv. (2021) 7:1–8. 10.1126/sciadv.abd4177 PubMed DOI PMC

Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med. (2021) 27:626–31. 10.1038/s41591-021-01292-y PubMed DOI PMC

Lu Y, Li X, Geng D, Mei N, Wu PY, Huang CC, et al. . Cerebral micro-structural changes in COVID-19 patients – an MRI-based 3-month Follow-up study: a brief title: cerebral changes in COVID-19. EClinicalMedicine. (2020) 25:100484. 10.1016/j.eclinm.2020.100484 PubMed DOI PMC

Morand A, Campion JY, Lepine A, Bosdure E, Luciani L, Cammilleri S, et al. . Similar patterns of [18F]-FDG brain PET hypometabolism in paediatric and adult patients with long COVID: a paediatric case series. Eur J Nucl Med Mol Imaging. (2021) 49:913–20. 10.21203/rs.3.rs-722537/v1 PubMed DOI PMC

Blazhenets G, Schroeter N, Bormann T, Thurow J, Wagner D, Frings L, et al. . Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 patients. J Nucl Med. (2021) 62:910–5. 10.2967/jnumed.121.262128 PubMed DOI PMC

Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M, et al. . Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. (2021) 144:1263–76. 10.1093/brain/awab009 PubMed DOI PMC

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2021) 397:220–32. 10.1016/S0140-6736(20)32656-8 PubMed DOI PMC

Morbelli S, Chiola S, Donegani MI, Arnaldi D, Pardini M, Mancini R, et al. . Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson's disease (PD) do not overlap. Eur J Nucl Med Mol Imaging. (2022) 46:1939–50. 10.1007/s00259-021-05666-9 PubMed DOI PMC

Hartman ME, Williams CN, Hall TA, Bosworth CC, Juan A, Program NR, et al. . Post-intensive care syndrome for the pediatric neurologist. Pediatr Neurol. (2021) 47–53. 10.1016/j.pediatrneurol.2020.02.003 PubMed DOI PMC

Smith JM, Lee AC, Zeleznik H, Scott JPC, Fatima A, Needham DM, et al. . Home and community-based physical therapist management of adults with post-intensive care syndrome. Phys Ther. (2020) 100:1062–73. 10.1093/ptj/pzaa059 PubMed DOI PMC

Gualtieri P, Falcone C, Romano L, Macheda S, Correale P, Arciello P, et al. . Body composition findings by computed tomography in sars-cov-2 patients: Increased risk of muscle wasting in obesity. Int J Mol Sci. (2020) 21:1–13. 10.3390/ijms21134670 PubMed DOI PMC

Callaway E, Ledford H. How bad is Omicron? What scientists know so far. Nature. (2021) 600:197–9. 10.1038/d41586-021-03614-z PubMed DOI

Peghin M, Bouza E, Fabris M, De Martino M, Palese A, Bontempo G, et al. . Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19. Eur J Clin Microbiol Infect Dis. (2021) 40:2597–604. 10.1007/s10096-021-04335-x PubMed DOI PMC

Iwasaki M, Saito J, Zhao H, Sakamoto A, Hirota K, Ma D. Inflammation triggered by SARS-CoV-2 and ACE2 augment drives multiple organ failure of severe COVID-19: molecular mechanisms and implications. Inflammation. (2021) 44:13–34. 10.1007/s10753-020-01337-3 PubMed DOI PMC

Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Prevalence and determinants of fatigue after covid-19 in non-hospitalized subjects: A population-based study. Int J Environ Res Public Health. (2021) 18:1–11. 10.3390/ijerph18042030 PubMed DOI PMC

Yarlagadda R, Joshi D. Post - COVID psychosis : a case report. SVOA Neurol. (2022)30–35.

LIU . No 主的健康感を中心とした在宅高者における健康指にする共分散造分析Title. (2020)151–156.

Carroll E, Neumann H, Aguero-Rosenfeld ME, Lighter J, Czeisler BM, Melmed K, et al. . Post–COVID-19 inflammatory syndrome manifesting as refractory status epilepticus. Epilepsia. (2020) 61:e135–9. 10.1111/epi.16683 PubMed DOI PMC

Sangare A, Dong A, Valente M, Pyatigorskaya N, Cao A, Altmayer V, et al. . Neuroprognostication of consciousness recovery in a patient with covid-19 related encephalitis: preliminary findings from a multimodal approach. Brain Sci. (2020) 10:1–13. 10.3390/brainsci10110845 PubMed DOI PMC

Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, et al. . Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. (2021). 10.1038/d41586-021-03827-2 PubMed DOI

Khoshkam Z, Aftabi Y, Stenvinkel P, Paige Lawrence B, Rezaei MH, Ichihara G, et al. . Recovery scenario and immunity in COVID-19 disease: a new strategy to predict the potential of reinfection. J Adv Res. (2021) 31:49–60. 10.1016/j.jare.2020.12.013 PubMed DOI PMC

Sciscent BY, Eisele CD, Ho L, King SD, Jain R, Golamari RR. COVID-19 reinfection: the role of natural immunity, vaccines, and variants. J Community Hosp Intern Med Perspect. (2021) 11:733–9. 10.1080/20009666.2021.1974665 PubMed DOI PMC

Kostopoulos IV, Orologas-Stavrou N, Rousakis P, Panteli C, Ntanasis-Stathopoulos I, Charitaki I, et al. . Recovery of innate immune cells and persisting alterations in adaptive immunity in the peripheral blood of convalescent plasma donors at eight months post sars-cov-2 infection. Microorganisms. (2021) 9:1–12. 10.3390/microorganisms9030546 PubMed DOI PMC

ishy HM, Al-Gareeb AI., Qusti S, Alshammari EM, Gyebi GA, Batiha GE-S. Covid-19-induced dysautonomia: a menace of sympathetic storm. ASN Neuro. (2021) 13:175909142110576. 10.1177/17590914211057635 PubMed DOI PMC

Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et al. . Diverse functional autoantibodies in patients with COVID-19. Nature. (2021) 595:283–8. 10.1101/2020.12.10.20247205 PubMed DOI

Hussman JP. Severe clinical worsening in COVID-19 and potential mechanisms of immune-enhanced disease. Front Med. (2021) 8:1–13. 10.3389/fmed.2021.637642 PubMed DOI PMC

Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. (2022) 185:881–95.e20. 10.1016/j.cell.2022.01.014 PubMed DOI PMC

Lorkiewicz P, Waszkiewicz N. Biomarkers of post-COVID depression. J Clin Med. (2021) 10:4142. 10.3390/jcm10184142 PubMed DOI PMC

Visvabharathy L, Hanson B, Orban Z, Lim PH, Nicole M, Jain R, et al. . Neuro–COVID long–haulers exhibit broad dysfunction in T cell memory generation and responses to vaccination. medRxiv [Preprint]. (2021) 2021.08.08.21261763. 10.1101/2021.08.08.21261763 PubMed DOI PMC

Kilpatrick M. Estimates of reduced vaccine effectiveness against hospitalization, infection, transmission and symptomatic disease of a new SARS-CoV-2 variant, Omicron (B.1.1.529), using neutralizing antibody titers. medrXiv [Preprint]. (2021)1–22. 10.1101/2021.12.10.21267594 DOI

Saxena SK, Kumar S, Ansari S, Paweska JT, Maurya VK, Tripathi AK. et al. Characterization of the novel SARS-CoV-2 omicron (B11529) variant of concern and its global perspective. J Med Virol. (2021) 94:1738–44. 10.1002/jmv.27524 PubMed DOI

Desforges M, Gurdasani D, Hamdy A, Leonardi AJ. Uncertainty around the long-term implications of COVID-19. Pathogens. (2021) 10:1–9. 10.3390/pathogens10101267 PubMed DOI PMC

Khateeb J, Li Y, Zhang H. Emerging SARS-CoV-2 variants of concern and potential intervention approaches. Crit Care. (2021) 25:1–8. 10.1186/s13054-021-03662-x PubMed DOI PMC

Jansen L, Tegomoh B, Lange K, Showalter K, Figliomeni J, Abdalhamid B. Investigation of a SARS-CoV-2 B. 1. 1. 529 (Omicron) Variant Cluster — Nebraska, November – December 2021. MMWR Morb Mortal Wkly Rep. (2021) 70:1782–4. 10.15585/mmwr.mm705152e3 PubMed DOI PMC

Hay JA, Kissler SM, Fauver JR, Mack C, Tai G, Samant RM, et al. . Viral dynamics and duration of PCR positivity of the SARS-CoV-2 Omicron variant. medrXiv [Preprint]. (2022).

Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes MPH MB ChB RC, Chen L, Deng J, et al. . Illness characteristics of COVID-19 in children infected with the SARS-CoV-2 Delta variant. medRxiv [Preprint]. (2021) 2021.10.06.21264467. 10.1101/2021.10.06.21264467 PubMed DOI PMC

Lee JJ, Choe YJ, Jeong H, Kim M, Kim S, Yoo H, et al. . Importation and transmission of variant of concern in Korea, November 2021. J Korean Med Sci. (2021) 36:e346. 10.3346/jkms.2021.36.e346 PubMed DOI PMC

Wang R, Chen J, Gao K, Hozumi Y, Yin C, Wei GW. Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants. Commun Biol. (2021) 4:1–14. 10.1038/s42003-021-01754-6 PubMed DOI PMC

Teyssou E, Delagrèverie H, Visseaux B, Lambert-Niclot S, Brichler S, Ferre V, et al. . The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients. J Infect. (2021) 83:e1–3. 10.1016/j.jinf.2021.08.027 PubMed DOI PMC

Meo SA, Meo AS, Al-Jassir FF, Klonoff DC. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics. Eur Rev Med Pharmacol Sci. (2021) 25:8012–8. 10.26355/eurrev_202112_27652 PubMed DOI

Albitar O, Ballouze R, Ooi JP, Sheikh Ghadzi SM. Risk factors for mortality among COVID-19 patients. Diabetes Res Clin Pract. (2020) 166:108293. 10.1016/j.diabres.2020.108293 PubMed DOI PMC

Volz E, Hill V, McCrone JT, Price A, Jorgensen D, O'Toole Á, et al. . Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell. (2021) 184:64–75. 10.1016/j.cell.2020.11.020 PubMed DOI PMC

Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants. Lancet. (2022) 399:2263–4. 10.1016/S0140-6736(22)00941-2 PubMed DOI PMC

Magnusson K, Kristoffersen DT, Isola AD. Post-covid medical complaints after SARS-CoV-2 Omicron vs Delta variants - a prospective cohort study. Nature. (2022) 697–707. 10.1101/2022.05.23.22275445 PubMed DOI PMC

Morioka S, Tsuzuki S, Suzuki M, Terada M, Akashi M, Osanai Y, et al. . Post COVID-19 condition of the Omicron variant of SARS-CoV-2. medRxiv [Preprint]. (2022) 603:706–14. 10.1101/2022.05.12.22274990 PubMed DOI PMC

Shazia P, Hakim T. OMICRON or B. 1. 1. 529: are we going back to point zero. SVOA Microbiol. (2021) 41–43.

Mulazim P, Bukhari H. Recently discovered omicron: fifth wave of pandemic in Pakistan. What strategies can be adopted to control its spread? JIIMC. (2021) 16:212–4. 10.47391/JPMA.22-60 DOI

Vihta K, Pouwels KB, Peto TEA, Pritchard E, House T, Studley R, et al. . Rourke E, Cook D, Diamond I. Authors. (2022)

de Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, et al. . COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med. (2021) 13:eabf8396. 10.1126/scitranslmed.abf8396 PubMed DOI PMC

Butowt R, Bilinska K. SARS-CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection. ACS Chem Neurosci. (2020) 11:1200–3. 10.1021/acschemneuro.0c00172 PubMed DOI

Piersiala K, Kakabas L, Bruckova A, Starkhammar M, Cardell LO. Acute odynophagia: a new symptom of COVID-19 during the SARS-CoV-2 omicron variant wave in Sweden. J Intern Med. (2022) 292:154–61. 10.1111/joim.13470 PubMed DOI PMC

Meng B, Abdullahi A, Ferreira IATM, Goonawardane N, Saito A, Kimura I, et al. . Altered TMPRSS2 usage by SARS-CoV-2 omicron impacts infectivity and fusogenicity. Nature. (2022) 603:706–14. 10.1038/s41586-022-04474-x PubMed DOI PMC

Peacock TP, Brown JC, Zhou J, Thakur N, Newman J, Kugathasan R, et al. . The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry. bioRxiv [Preprint]. (2022) 78:798–812. 10.1101/2021.12.31.474653 DOI

Abdullah F, Myers J, Basu D, Tintinger G, Ueckermann V, Mathebula M, et al. . Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa. Int J Infect Dis. (2022) 116:38–42. 10.1016/j.ijid.2021.12.357 PubMed DOI PMC

Pfortmueller CA, Spinetti T, Urman RD, Luedi MM, Schefold JC. COVID-19-associated acute respiratory distress syndrome (CARDS): current knowledge on pathophysiology and ICU treatment – a narrative review. Best Pract Res Clin Anaesthesiol. (2021) 35:351–68. 10.1016/j.bpa.2020.12.011 PubMed DOI PMC

Cloete J, Kruger A, Masha M, Plessis NM, Mawela D. Rapid rise in paediatric COVID-19 hospitalisations during the early stages of the omicron wave, Tshwane District, South Africa. medRxiv [Preprint]. (2021) 1–18. 10.1101/2021.12.21.21268108 DOI

Li A, Maier A, Carter M, Hugh Guan T. Omicron and s-gene target failure cases in the highest COVID-19 case rate region in Canada — December 2021. J Med Virol. (2021) 10–12. PubMed PMC

Mohiuddin M, Kasahara K. Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options. Respir Med. (2021) 191:106716. 10.1016/j.rmed.2021.106716 PubMed DOI PMC

Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Amoako DG, et al. . Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa. (2021) 1–23. 10.1101/2021.12.21.21268116 PubMed DOI PMC

Bálint G, Vörös-Horváth B, Széchenyi A. Omicron: increased transmissibility and decreased pathogenicity. Signal Transduct Target Ther. (2022) 7:2–4. 10.1038/s41392-022-01009-8 PubMed DOI PMC

Passos GS, Poyares D, Santana MG, Teixeira AADS, Lira FS, Youngstedt SD, et al. . Exercise improves immune function, antidepressive response, and sleep quality in patients with chronic primary insomnia. Biomed Res Int. (2014) 2014:498961. 10.1155/2014/498961 PubMed DOI PMC

Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. . Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. (2020) 15:1–12. 10.1371/journal.pone.0240784 PubMed DOI PMC

Lemhöfer C, Sturm C, Loudovici-Krug D, Best N, Gutenbrunner C. The impact of post-COVID-syndrome on functioning – results from a community survey in patients after mild and moderate SARS-CoV-2-infections in Germany. J Occup Med Toxicol. (2021) 16:1–9. 10.1186/s12995-021-00337-9 PubMed DOI PMC

Sedgwick P. Cross sectional studies: advantages and disadvantages. BMJ. (2014) 348:1–2. 10.1136/bmj.g2276 PubMed DOI

Camm AJ, Fox KAA. Strengths and weaknesses of ‘real-world' studies involving non-vitamin K antagonist oral anticoagulants. Open Hear. (2018) 5:e000788. 10.1136/openhrt-2018-000788 PubMed DOI PMC

Caruana EJ, Roman M, Hernández-Sánchez J, Solli P. Longitudinal studies. J Thorac Dis. (2015) 7:E537–40. 10.3978/j.issn.2072-1439.2015.10.63 PubMed DOI PMC

Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, et al. . Altered lipid metabolism in recovered SARS patients twelve years after infection. Sci Rep. (2017) 7:1–12. 10.1038/s41598-017-09536-z PubMed DOI PMC

Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mulè G, et al. . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. (2022) 28:611.e9–1.e16. 10.1016/j.cmi.2021.11.002 PubMed DOI PMC

Aiash H, Khodor M, Shah J, Ghozy S, Sheble A, Hassan A, et al. . Integrated multidisciplinary post-COVID-19 care in Egypt. Lancet Glob Heal. (2021) 9:e908–9. 10.1016/S2214-109X(21)00206-0 PubMed DOI PMC

Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. (2021) 75:1–5. 10.1111/ijcp.13746 PubMed DOI PMC

Hulme KD, Noye EC, Short KR, Labzin LI. Dysregulated inflammation during obesity: driving disease severity in influenza virus and SARS-CoV-2 infections. Front Immunol. (2021) 12:1–25. 10.3389/fimmu.2021.770066 PubMed DOI PMC

Butt AA, Khan T, Yan P, Shaikh OS, Omer SB, Mayr F. Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination. J Infect. (2021) 83:237–79. 10.1016/j.jinf.2021.05.021 PubMed DOI PMC

Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. (2018) 14:576–90. 10.1038/s41574-018-0059-4 PubMed DOI

Ahmadi Hekmatikar AH, Ferreira Júnior JB, Shahrbanian S, Suzuki K. Functional and psychological changes after exercise training in post-covid-19 patients discharged from the hospital: a PRISMA-compliant systematic review. Int J Environ Res Public Health. (2022) 19:2290. 10.3390/ijerph19042290 PubMed DOI PMC

Romeo J, Wärnberg J, Pozo T, Marcos A. Physical activity, immunity and infection. Proc Nutr Soc. (2010) 69:390–9. 10.1017/S0029665110001795 PubMed DOI

Laddu DR, Lavie CJ, Phillips SA, Arena R. Since january 2020 elsevier has created a COVID-19 resource centre with free information in english and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on elsevier connect, the company' s public news and information. Prog Cardiovasc Dis. (2020) 64:102–4. PubMed

Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, Martínez-Cava A, Franco-López F, Sánchez-Alcaraz Martínez BJ, et al. . Post-covid-19 syndrome and the potential benefits of exercise. Int J Environ Res Public Health. (2021) 18:5329. 10.3390/ijerph18105329 PubMed DOI PMC

Rudroff T, Workman CD, Ponto LLB. 18 F-FDG-PET imaging for post-COVID-19 brain and skeletal muscle alterations. Viruses. (2021) 13:2283. 10.3390/v13112283 PubMed DOI PMC

Rudroff T, Kamholz J, Fietsam AC, Deters JR, Bryant AD. Post-covid-19 fatigue: potential contributing factors. Brain Sci. (2020) 10:1–7. 10.3390/brainsci10121012 PubMed DOI PMC

Hayden MC, Limbach M, Schuler M, Merkl S, Schwarzl G, Jakab K, et al. . Effectiveness of a three-week inpatient pulmonary rehabilitation program for patients after COVID-19: a prospective observational study. Int J Environ Res Public Health. (2021) 18:9001. 10.3390/ijerph18179001 PubMed DOI PMC

Hu CC, Huang JW, Wei N, Hu SH, Hu JB Li SG, et al. . Interpersonal psychotherapy-based psychological intervention for patient suffering from COVID-19: a case report. World J Clin Cases. (2020) 8:6064–70. 10.12998/wjcc.v8.i23.6064 PubMed DOI PMC

Workman C, Boles-Ponto L, Kamholz J, Bryant A, Rudroff T. Transcranial direct current stimulation and post-COVID-19-fatigue. Brain Stimul. (2021) 14:1672–3. 10.1016/j.brs.2021.10.268 DOI

Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. (2021) 69:205–11. 10.1007/s12026-021-09185-5 PubMed DOI PMC

Segerstrom SC, Nes LS. Heart rate variability reflects self-regulatory strength, effort, and fatigue. Psychol Sci. (2007) 18:275–81. 10.1111/j.1467-9280.2007.01888.x PubMed DOI

Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. (2010) 141:122–31. 10.1016/j.ijcard.2009.09.543 PubMed DOI

Chandra RK. Nutrition, immunity and infection: From basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival. Proc Natl Acad Sci U S A. (1996) 93:14304–7. 10.1073/pnas.93.25.14304 PubMed DOI PMC

Calder PC. Nutrition, immunity and COVID-19. BMJ Nutr Prev Heal. (2020) 3:74–92. 10.1136/bmjnph-2020-000085 PubMed DOI PMC

Yeoh YK, Zuo T, Lui GCY, Zhang F, Liu Q, Li AYL, et al. . Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. (2021) 70:698–706. 10.1136/gutjnl-2020-323020 PubMed DOI PMC

Syndrome C-. Nutritional modulation of gut microbiota alleviates severe gastrointestinal symptoms in a patient with post-acute. mBio. (2022) 13:e0380121. 10.1128/mbio.03801-21 PubMed DOI PMC

Frame LA, Costa E, Jackson SA. Current explorations of nutrition and the gut microbiome: A comprehensive evaluation of the review literature. Nutr Rev. (2020) 78:798–812. 10.1093/nutrit/nuz106 PubMed DOI